Weight Loss

Tirzepatide beats Wegovy?

Mounjaro Tirzepatide Diabetes 2 and Weight Loss

Will Mounjaro Tirzepatide (a new diebetic drug) outdo Wegovy and Saxenda for weight loss in 2023? Many argue it will as research studies show weight loss was even greater among individuals injected with Tirzaptide during a diabeties clinical trial. This newly FDA-approved diabetes medication is being studied as a potential weight-loss power drug. Early research is more than just positive!

Wegovy - Ozempic for Weight Loss Costa Rica

Losing Weight Injections GLP-1

In clinical studies, Wegovy has been shown to be effective for weight loss in adults who are obese or overweight. In a clinical trial involving 3,731 participants, those who received Wegovy lost an average of 15.3% of their body weight over 68 weeks, compared to 2.6% for those who received a placebo.

es_CRES
Scroll to Top